Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sankyo patents new antitumor compounds

June 20, 2002

CoFactor phase II trial design finalized

June 20, 2002

Biological activity of paclitaxel-glucose conjugate tested in human cancer cell lines

June 20, 2002

Abbott identifies aryl tetrahydropyridine farnesyltransferase inhibitors

June 20, 2002

131I-TM-601 to enter phase I/II for glioma

June 19, 2002

Lorus and NCI collaborate on GTI-2040 phase II program

June 19, 2002

AxCell enters into CRADA with NCI to research TEY1 for prostate cancer

June 19, 2002

Isis and Lilly expand antisense alliance into cancer

June 19, 2002

Preliminary clinical data reported for components of gene-directed enzyme prodrug therapy

June 19, 2002

AEterna updates Neovastat progress

June 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...